Mitsubishi Tanabe wins the race to snag the first new ALS drug OK in more than 20 years
After being recruited by the FDA, Mitsubishi Tanabe has won the agency’s approval to start selling edaravone as a new treatment for ALS — the first …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
